Johann Mcloughlin - Wuhan General Head Design

WUHNDelisted Stock  USD 0.0004  0.00  0.00%   

Insider

Johann Mcloughlin is Head Design of Wuhan General Gr
Phone514-928-7368
Webhttps://wuhn.org

Wuhan General Management Efficiency

Wuhan General's management efficiency ratios could be used to measure how well Wuhan General manages its routine affairs as well as how well it operates its assets and liabilities.
Wuhan General Gr currently holds 118.8 M in liabilities with Debt to Equity (D/E) ratio of 1.11, which is about average as compared to similar companies. Wuhan General Gr has a current ratio of 1.08, suggesting that it may not have the ability to pay its financial obligations when due. Debt can assist Wuhan General until it has trouble settling it off, either with new capital or with free cash flow. So, Wuhan General's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Wuhan General Gr sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Wuhan to invest in growth at high rates of return. When we think about Wuhan General's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Avi KrivorotCannara Biotech
N/A
Anthony ManoukCannara Biotech
N/A
Andrew StordeurSNDL Inc
44
Corey SheahanAcreage Holdings
N/A
Matthew DarinCuraleaf Holdings
N/A
Bryan MurrayAcreage Holdings
N/A
Carlos MueteAvicanna
N/A
Thomas LarssenAurora Cannabis
N/A
Michael DetlefsenAurora Cannabis
56
Theresa FirestoneAurora Cannabis
65
Etienne LedouxCannara Biotech
N/A
Robbie MadanSNDL Inc
45
Nick EttenAcreage Holdings
N/A
Zachary IVSNDL Inc
46
Patricia RosiAcreage Holdings
N/A
James ShorrisCuraleaf Holdings
61
Kevin GiffordCronos Group
N/A
Brian ShermanCannara Biotech
N/A
David AbitbolCannara Biotech
N/A
Jason GreenCanopy Growth Corp
N/A
Edward KremerCuraleaf Holdings
51
Wuhan General Group , Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol -based products under the Dr. Wuhan General Group , Inc. is headquartered in Pointe-Claire, Canada. Wuhan General operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 700 people. Wuhan General Gr [WUHN] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. Wuhan General is listed under Machinery category by Fama And French industry classification.

Management Performance

Wuhan General Gr Leadership Team

Elected by the shareholders, the Wuhan General's board of directors comprises two types of representatives: Wuhan General inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Wuhan. The board's role is to monitor Wuhan General's management team and ensure that shareholders' interests are well served. Wuhan General's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Wuhan General's outside directors are responsible for providing unbiased perspectives on the board's policies.
Anna Morera, Chief Medical Officer
Carol Pan, Principal Officer
Luka MSc, Director Communication
Huang Zhaoqi, Vice Director
Johann Mcloughlin, Head Design
Shivani Subudhi, Head Marketing
Willem Jonker, Chief Officer
Samuel Williams, Head Foods
Jeffrey Robinson, Chairman Founder
AAg MSc, Chief Officer

Wuhan Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Wuhan General a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Wuhan General

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Wuhan General position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wuhan General will appreciate offsetting losses from the drop in the long position's value.

Moving together with Wuhan Pink Sheet

  0.67EGRX Eagle PharmaceuticalsPairCorr

Moving against Wuhan Pink Sheet

  0.72INIS International IsotopesPairCorr
  0.54ELTP Elite PharmaPairCorr
  0.45YCBD-PA cbdMD IncPairCorr
  0.38VAXX VaxxinityPairCorr
The ability to find closely correlated positions to Wuhan General could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Wuhan General when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Wuhan General - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Wuhan General Gr to buy it.
The correlation of Wuhan General is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Wuhan General moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Wuhan General Gr moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Wuhan General can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in Wuhan Pink Sheet

If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities